MED - Medifast, Inc.
| Previous Close | 214.73 |
| Open | 214.91 |
| Bid | 0.00 x 1100 |
| Ask | 0.00 x 1100 |
| Day's Range | 212.69 - 218.67 |
| 52 Week Range | 60.60 - 260.98 |
| Volume | 131,744 |
| Avg. Volume | 271,603 |
| Market Cap | 2.597B |
| Beta (3Y Monthly) | -0.16 |
| PE Ratio (TTM) | 65.46 |
| EPS (TTM) | 3.32 |
| Earnings Date | Nov 5, 2018 - Nov 9, 2018 |
| Forward Dividend & Yield | 1.92 (0.91%) |
| Ex-Dividend Date | 2018-09-20 |
| 1y Target Est | 229.00 |
- Zacks•2 days ago
SYY or MED: Which Is the Better Value Stock Right Now?
SYY vs. MED: Which Stock Is the Better Value Option?
- Zacks•22 days ago
Hain Celestial to Gain From Project Terra, Soft Sales a Woe
Hain Celestial (HAIN) is expected to further gain from its Project Terra program and strategic acquisitions amid high expenses and soft U.S. segment sales.
- Zacks•24 days ago
5 Defensive Stocks to Buy as Trade Tensions Take a New Turn
Given that both the United States and China are imposing tit-for-tat tariffs, the trade war is unlikely to end anytime soon.
- Zacks•24 days ago
Zacks.com featured highlights include: Conduent, Medifast, Commvault, Molina and Fortinet
Zacks.com featured highlights include: Conduent, Medifast, Commvault, Molina and Fortinet
- Zacks•27 days ago
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
- Zacks•27 days ago
MEDIFAST Sees Hammer Chart Pattern: Time to Buy?
MEDIFAST has been struggling lately, but the selling pressure may be coming to an end soon.
Bloomberg•27 days agoMedifast Shares Are Volatile After Gotham Releases Short Report
Medifast Inc., the weight-loss program provider whose shares have tripled this year, was whipsawed Thursday by a short-seller’s report claiming the company hasn’t disclosed contaminants in its supplements. The new short report from Gotham City Research claims that Medifast was aware of elevated levels of lead and other toxic metals in its Optavia product line. Gotham also criticizes the company’s supply chain and aggressive pricing.
- InvestorPlace•29 days ago
Buy Medifast Stock as It Continues to Soar
Now, when I say Medifast (NYSE:MED) is gaining while its customers are losing, that’s a good thing. You see, MED stock is a weight loss management company. Sure, it’s easy for a small firm with a small market cap to double its business and its stock price.
- Thomson Reuters StreetEvents•last month
Edited Transcript of MED earnings conference call or presentation 3-May-18 8:30pm GMT
Q1 2018 Medifast Inc Earnings Call
- Zacks•last month
Zacks.com highlights: athenahealth, Medifast, Commvault Systems, Molina Healthcare and Fortinet
Zacks.com highlights: athenahealth, Medifast, Commvault Systems, Molina Healthcare and Fortinet
- PR Newswire•last month
Medifast, Inc. Announces Quarterly Dividend
BALTIMORE, Sept. 6, 2018 /PRNewswire/ -- Medifast, Inc. (MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, announced today that its Board of Directors has declared a $0.48 cash dividend to its stockholders. The quarterly cash dividend of $0.48 per share is payable on November 8, 2018 to stockholders of record as of the close of business on September 21, 2018. The Company expects to maintain a program of paying dividends on a quarterly basis. However, the declaration of dividends in the future is subject to the discretion of the Medifast Board of Directors, who will evaluate the Company's dividend program from time to time based on factors that it deems relevant.
- InvestorPlace•last month
Bet on These 5 Top Liquid Stocks for Stellar Returns
Liquidity indicates a company’s capability of meeting debt obligations by converting assets into liquid cash and equivalents. It considers inventory excluding current assets relative to current liabilities.
- Thomson Reuters StreetEvents•last month
Edited Transcript of MED earnings conference call or presentation 2-Aug-18 8:30pm GMT
Q2 2018 Medifast Inc Earnings Call
- Zacks•last month
The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast
The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast
- Zacks•2 months ago
Trump's Approval Rating Buoy Wall Street: 4 Top Gainers
Trump's pro-growth agenda has worked wonders for the economy as a whole.
- Zacks•2 months ago
Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting
Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting
- InvestorPlace•2 months ago
Buy These 5 Low-Beta Stocks to Brave Market Volatility
Success in stock market investing comes from intense research and analysis and not from taking leaps in the dark.Source: Shutterstock
- InvestorPlace•2 months ago
Medifast Stock Is Still Worth Pouring Into
Medifast (NYSE:MED) announced Q2 earnings at the beginning of the month and they were stunning. Revenue was up 55% and its flagship Optavia brand brought in 64% of that revenue. Net income was up 86%. Earnings-per-share were up 84%. After those kinds of results, with similarly impressive results for a few quarters now, it’s not too surprising that MED stock is up a whopping 198% year-to-date.
- Zacks•2 months ago
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
- MarketWatch•2 months ago
S&P 500 is stalling, but these 3 sectors are scaling fresh highs like clockwork
Momentum could be pointing to big gains going forward for these sectors — regardless of how long the S&P takes to break out.
- Zacks•2 months ago
Zacks.com highlights: Medifast, Continental Building Products, Huntsman, Logitech International and Allison Transmission Holdings
Zacks.com highlights: Medifast, Continental Building Products, Huntsman, Logitech International and Allison Transmission Holdings
- Zacks•2 months ago
5 Top Momentum Stocks Powered by Driehaus Strategy
Richard Herman Driehaus who is a well-known American businessman and fund manager, developed an investment approach based on the buy high and sell higher rule.
